Gensaic enters into collaboration to develop phage-derived gene therapies for central nervous system
Ovid turns to gene therapy startup to restock drug pipeline
Ovid Therapeutics partners up with gene therapy startup
Ovid and Gensaic enter strategic CNS collaboration
M13 Therapeutics awarded in Harvard's 2022 President's Innovation Challenge (PIC)
M13 Therapeutics wins Golden Ticket sponsored by BioMarin Pharmaceutical Inc.
M13 Therapeutics awarded "Future Innovator Prize" by Astellas Pharma Inc.
M13 Therapeutics wins Golden Ticket sponsored by MilliporeSigma